IRS-2 rs1805097 polymorphism is associated with the decreased risk of colorectal cancer.
Oncotarget 2017 Feb .
Yin Jiefeng, Zhang Zhe, Zheng Huajun, Xu L
Lack of association between insulin receptor substrate2 rs1805097 polymorphism and the risk of colorectal and breast cancer: a meta-analysis.
PloS one 2014 9 (1): e86911.
Hu Yue, Zhou Min, Zhang Kai, Kong Xiangquan, Hu Xiaoyan, Li Kang, Liu